Condition: Congenital Myotonic Dystrophy · CDM · Sponsor: Virginia Commonwealth University
The overall goal of the study is to establish valid clinical endpoint assessments for children with congenital myotonic dystrophy type 1 and develop biomarkers for the condition.
This description comes directly from the study's public registry record.
Ruby Langeslay · 804-828-8481 · ruby.langeslay@vcuhealth.org
Jennifer Raymond · 804-828-6318 · jennifer.raymond@vcuhealth.org
Always discuss trial participation with your own doctor first.
| University of California, Los Angeles | Los Angeles, California, United States | Recruiting |
| University of Kansas Medical Center | Fairway, Kansas, United States | Recruiting |
| University of Rochester Medical Center | Rochester, New York, United States | Recruiting |
| Virginia Commonwealth University | Richmond, Virginia, United States | Recruiting |
| Centro Clinico NeMO | Milan, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05224778